Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Itamar Medical Ltd receives FDA clearance for newest model of WatchPATDevice - WatchPATUnified


Monday, 9 Jun 2014 10:05am EDT 

Itamar Medical Ltd:Newest model of WatchPAT device, considered advanced home sleep diagnostic device in market, allows test to be performed using single finger to collect both oximetry and PAT data in Unified probe.WatchPAT Unified device is FDA approved to diagnose sleep apnea with sleep stages, using most innovative technology to ensure reliable, accurate, and simple sleep apnea diagnostic experience for the patient in the home setting.Itamar Medical Receives FDA Clearance for Newest Model of WatchPAT Device - WatchPAT Unified Itamar Medical reported on June 9th, 2014, that new and upgraded model of the WatchPAT, Itamar Medical's leading sleep apnea diagnostic device, has been cleared by the FDA.This model has received lot of hype from physician and sleep expert attendees.Within WatchPAT Unified, patented PAT sensor will measure blood oxygen saturation in addition to the PAT signal in single Unified probe.In previous models of WatchPAT, patient wore watch-like device on wrist with two finger sensors attached to it, one measuring the PATsignal and one oximetry sensor measuring blood oxygen saturation.Newest model, which features a single unified finger probe (see picture), simplifies the test procedure, and improves reliability and user comfort while taking the test. 

Related Company News

Company Quote

191.0
-5.4 -2.75%
9:24am EST